These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3137063)

  • 1. Slow-release isosorbide-5-mononitrate--a new once daily therapeutic modality for angina pectoris.
    Ahmadinejad M; Eghbal B; Sorgenicht W; Schneeweiss A; Weiss M
    Eur Heart J; 1988 Jan; 9 Suppl A():135-9. PubMed ID: 3137063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antianginal efficacy and tolerability of 50 mg sustained-release isosorbide 5-mononitrate in an open twelve-month observation study.
    Heepe W; Gathmann-Lewik U
    Cardiology; 1987; 74 Suppl 1():34-9. PubMed ID: 3111689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized crossover trial of isosorbide mononitrate (Elantan 20) and slow-release glyceryl trinitrate in the treatment of angina pectoris.
    Brodie NH; O'Hara H; O'Hara J; Valle-Jones JC
    Pharmatherapeutica; 1985; 4(6):367-75. PubMed ID: 3936056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the antianginal and anti-ischemic efficacy of slow-release isosorbide-5-mononitrate capsules, bupranolol and their combination, in patients with chronic stable angina pectoris.
    Krepp HP
    Cardiology; 1991; 79 Suppl 2():14-8. PubMed ID: 1760823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate.
    Thadani U; Maranda CR; Amsterdam E; Spaccavento L; Friedman RG; Chernoff R; Zellner S; Gorwit J; Hinderaker PH
    Ann Intern Med; 1994 Mar; 120(5):353-9. PubMed ID: 8093132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily, and isosorbide dinitrate twice daily in patients with chronic stable angina.
    Walker JM; Curry PV; Bailey AE; Steare SE
    Int J Cardiol; 1996 Feb; 53(2):117-26. PubMed ID: 8682597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in a slow-release form on exercise-induced myocardial ischemia.
    Hennig L; Andresen D; Hennig A; Levenson B; Brüggemann T; Schröder R
    J Clin Pharmacol; 1991 Jul; 31(7):636-40. PubMed ID: 1894759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isosorbide 5-mononitrate: a review of a sustained-release formulation (Imdur) in stable angina pectoris.
    Gunasekara NS; Noble S
    Drugs; 1999 Feb; 57(2):261-77. PubMed ID: 10188765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of coronary heart disease with isosorbide mononitrate ('Elantan' 20): a multi-centre study in hospital and general practice.
    Marten W; Weiss M; Haase W
    Curr Med Res Opin; 1984; 9(2):96-106. PubMed ID: 6443349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intraindividual dose-response relationship of sustained-release Elantan].
    Kenedi P
    Z Kardiol; 1986; 75 Suppl 3():77-9. PubMed ID: 3541420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris.
    Chrysant SG; Glasser SP; Bittar N; Shahidi FE; Danisa K; Ibrahim R; Watts LE; Garutti RJ; Ferraresi R; Casareto R
    Am J Cardiol; 1993 Dec; 72(17):1249-56. PubMed ID: 8256699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once- versus twice-daily administration of controlled-release isosorbide-5-mononitrate 60 mg in the treatment of stable angina pectoris. A randomized, double-blind, cross-over study. The Swedish Multicentre Group.
    Nordlander R; Walter M
    Eur Heart J; 1994 Jan; 15(1):108-13. PubMed ID: 8174569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of effects and tolerance of slow-release isosorbide-5-mononitrate for angina pectoris.
    Thadani U; Hamilton SF; Olson E; Anderson JL; Prasad R; Voyles W; Doyle R; Kirsten E; Teague SM
    Am J Cardiol; 1987 Apr; 59(8):756-62. PubMed ID: 3825935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and duration of action of isosorbide-5-mononitrate in the treatment of stable angina of effort. Comparison with sustained-release isosorbide dinitrate].
    Lagioia R; Scrutinio D; Mangini SG; De Toma L; Accettura D; De Nicolò M; Saliani P; Preziusi N; Antuofermo F; Rizzon P
    G Ital Cardiol; 1985 Mar; 15(3):299-306. PubMed ID: 4018470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short and long-acting oral nitrates for stable angina pectoris.
    Thadani U; Lipicky RJ
    Cardiovasc Drugs Ther; 1994 Aug; 8(4):611-23. PubMed ID: 7848896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained-release isosorbide mononitrate (50 mg): optimization of a once-daily dosage form for long-term treatment of angina pectoris.
    Bonn R
    Am J Cardiol; 1988 Mar; 61(9):12E-14E. PubMed ID: 3348135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
    Parker JO
    Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term efficacy of a controlled-release formulation of isosorbide 5-mononitrate (Imdur) in angina patients receiving beta-blockers.
    Uusitalo A
    Drugs; 1987; 33 Suppl 4():111-7. PubMed ID: 2887418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
    Thadani U
    Z Kardiol; 1985; 74 Suppl 4():21-4. PubMed ID: 4096067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained-release IS-5-MN in the treatment of coronary heart disease.
    Keck M
    Cardiology; 1991; 79 Suppl 2():51-7. PubMed ID: 1760831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.